SEC Form 4 · accession 0000899243-17-015813
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith T. Flaherty
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 8, 2017 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $59.56 | Jun 8, 2017 | A | 10,000 | A | — | Jun 8, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant.